The simultaneous inhibition of BRD4 and PLK1 enzymes by a single small molecule has shown a synergistic effect in the treatment of several types of cancers by increasing apoptosis and decreasing cancer cell proliferation with reduced toxicity [23]. The gene discussed is PLK1; the disease is cancer.